Vaccines need to be kept under a specific temperature, so that their chemical structure does not get changed. However, there are chances that the situation would change a bit for some medicines and would also save a lot of money being used to spend vaccines to maintain their chemical specifications.

A research has been taken out by a group of researchers from the Tufts University School of Engineering, in Massachusetts. Study researchers involved in the research have developed a silk-based stabilizer, which is capable of maintaining the temperature of some of the vaccines and antibiotics up to the temperature of 60 degrees Celsius.

The research was being led by two doctoral fellows David Kaplan and Jeney Zhang, said that maintaining the chemical structure of the vaccine is a costly affair. It requires a specific temperature under which medicines needs to be preserved.

In order to offer an economic option, Kaplan said that they have developed this stabilizer, which uses a special formula that will protect bioactive elements, which further makes sure that the vaccine is not destroyed.

"This could potentially eliminate the need for a cold chain system, greatly decreasing costs and enabling more widespread availability of these life-saving drugs", said Kaplan.